Anticoagulants: A Patient Guide to Understanding Your Treatment

Citable definition: Anticoagulants are medications that reduce the blood’s ability to form clots (coagulation), used to prevent or treat serious vascular conditions such as deep vein thrombosis, pulmonary embolism, or certain cardiac disorders like atrial fibrillation.

What Is an Anticoagulant?

If your doctor has prescribed an anticoagulant, you probably have many questions. That is perfectly normal: this type of treatment requires a good understanding to be followed safely. At Petit Veinard, we believe that a well-informed patient is a better-protected patient.

Blood has a natural mechanism to stop bleeding: coagulation. When this mechanism overactivates or triggers in the wrong place, it can form a thrombus (blood clot) inside a vessel. This clot can block blood flow locally, or travel to the lungs (pulmonary embolism) or the brain (stroke).

Anticoagulants do not dissolve existing clots. Instead, they slow down and prevent the formation or extension of new clots. They act on different steps of the coagulation cascade — the chain reaction that leads to clot formation.

There are two main families of oral anticoagulants in use today:

• Vitamin K antagonists (VKAs), such as warfarin (Coumadin) or acenocoumarol, used for decades. They require regular blood tests (INR) to adjust the dose.
• DOACs (Direct Oral Anticoagulants), such as rivaroxaban (Xarelto), apixaban (Eliquis), or dabigatran (Pradaxa). More recent, they typically have a fixed dose and require less laboratory monitoring.

To learn more about the vascular conditions these medications treat, see our treatments section.

Why Were You Prescribed an Anticoagulant?

The indications are varied. According to Sirkin et al. (Polish Archives of Internal Medicine, 2026), DOACs are now widely prescribed for the management of venous thromboembolism (VTE) — the medical term encompassing deep vein thrombosis and pulmonary embolism — as well as atrial fibrillation (an irregular heart rhythm that increases stroke risk) and following certain surgeries.

The most common situations requiring anticoagulant therapy include:

• Deep vein thrombosis (DVT): a blood clot in a deep vein, often in the leg
• Pulmonary embolism: a clot that has traveled to the lungs
• Atrial fibrillation (AF): an irregular heartbeat that increases stroke risk
• Post-surgical prevention: particularly after orthopedic surgery (hip or knee replacement)
• Mechanical heart valves: to prevent clots forming on the prosthesis

Symptoms to Watch for During Treatment

Taking an anticoagulant means finding a delicate balance: too little effect, and the clot risk persists; too much effect, and the bleeding risk increases. That is why it is essential to recognize warning signs.

Signs of Underdosing (Insufficient Treatment)

• Pain, swelling, or redness in a calf (possible sign of DVT)
• Sudden shortness of breath or chest pain (possible sign of pulmonary embolism)
• Sudden neurological deficit: paralysis, speech difficulty (possible sign of stroke)

Signs of Overdosing (Excessive Treatment)

• Bleeding from gums or nose without clear cause
• Pink or red urine (hematuria)
• Black or bloody stools
• Large, spontaneous bruises
• Prolonged bleeding after a minor cut

In case of heavy bleeding or suspected stroke or pulmonary embolism, call emergency services immediately.

How Are Diagnosis and Monitoring Organized?

Your doctor prescribed an anticoagulant based on a clinical and laboratory assessment. Depending on the type of treatment, monitoring differs:

For VKAs (Warfarin)

A blood test called the INR (International Normalized Ratio, a measure of how quickly the blood clots) is performed regularly — sometimes weekly at first, then every 4 to 6 weeks once stable. The dose is adjusted based on this result to keep you within a precise therapeutic range.

For DOACs

These medications have the advantage of a fixed dose without routine coagulation monitoring. However, kidney function testing (creatinine) is recommended at least once a year, because some DOACs are cleared by the kidneys. Impaired kidney function can alter drug levels in the blood.

Shrestha et al. (Cureus, 2025) demonstrated in a quality improvement study that enhancing DOAC initiation procedures — particularly verifying kidney function and checking drug interactions from the outset — significantly reduced prescribing errors and patient risk.

Anticoagulant Treatments: Comparison Table

Burnett et al. (2016) published a practical reference guide for DOAC management in VTE treatment, detailing special situations (surgery, renal impairment, pregnancy) where adjustments are necessary.

Patient Education: A Key Often Overlooked

Anticoagulant therapy is only effective if the patient understands it and takes it correctly. Several recent studies highlight this point.

Cohen et al. (Patient Education and Counseling, 2026) conducted the EDUC-AOD study, demonstrating that structured pharmaceutical counseling sessions significantly improve DOAC patients’ knowledge and medication adherence (taking the treatment as prescribed). Better-informed patients make fewer dosing errors and report adverse effects more promptly.

Similarly, Leclerc et al. (European Journal of Hospital Pharmacy, 2026) evaluated a 9-year educational program for patients on oral anticoagulants in a cardiology department. The result: structured patient education durably improves treatment understanding and patient safety.

These findings confirm what Barcellona et al. (2002) had already established: patient education is a fundamental pillar of anticoagulant management, reducing both bleeding and thrombotic complications.

Do not hesitate to ask your pharmacist for a dedicated counseling session about your anticoagulant therapy. Many pharmacies offer this service, and it can make a real difference in treatment safety.

Prevention and Daily Life on Anticoagulants

Taking an anticoagulant does not mean living in a bubble. Here are practical tips for your daily routine:

Diet

• VKAs only: avoid sudden changes in your consumption of vitamin K-rich foods (kale, spinach, broccoli). These foods are not forbidden — consistency is key.
• For all anticoagulants: limit alcohol, which can potentiate the anticoagulant effect.

Physical Activity

Regular physical activity is encouraged to promote healthy blood circulation and reduce thrombosis risk. Simply avoid high-impact contact sports with significant injury risk (boxing, rugby, etc.).

Medications to Avoid Without Medical Advice

Certain common medications interact with anticoagulants:

• Aspirin and NSAIDs (ibuprofen, naproxen): increase bleeding risk
• St. John’s wort (herbal supplement): reduces DOAC effectiveness
• Antibiotics: can alter INR in patients on VKAs

Pandya and Bajorek (2017) analyzed factors influencing anticoagulant adherence and found that perceived treatment complexity and fear of bleeding are the main causes of poor adherence. Clear, personalized information is essential to address these barriers.

Special Situations to Anticipate

• Surgery or dental procedures: always inform the surgeon or dentist that you are on an anticoagulant. Temporary discontinuation or bridging therapy may be needed.
• Air travel: prolonged immobility increases DVT risk. Wearing compression stockings is often recommended alongside anticoagulant therapy.
• Pregnancy: DOACs are contraindicated during pregnancy. Inform your doctor immediately.

Aldossari et al. (Pharmacy (Basel), 2026) noted that healthcare professionals themselves identify drug interactions and high-risk situations as the main clinical challenges in daily DOAC management, underscoring the importance of coordination between physicians and pharmacists.

When to Seek Emergency or Routine Medical Care

Call emergency services immediately if:

• Heavy bleeding that will not stop
• Large amounts of blood in urine or black stools
• Chest pain, sudden shortness of breath
• Sudden severe headache, paralysis, or speech difficulty
• A fall with a head injury

See your doctor promptly if:

• You have missed several doses
• You need to undergo a procedure (even a dental one)
• You have started a new medication, even an over-the-counter one
• You are pregnant or planning a pregnancy
• You notice unusual or frequent bruising

Ask your pharmacist about:

• Checking interactions with a new medication or dietary supplement
• Understanding how to manage a missed dose
• Getting a dedicated counseling session on your treatment

References

1. Leclerc E, Cavagna P, Cuquel AC, et al. Nine years’ experience of an educational programme for patients treated with oral anticoagulants in a cardiology department. European Journal of Hospital Pharmacy. 2026. DOI: 10.1136/ejhpharm-2024-004372

2. Aldossari DS, Latif K, Alsadoni AN, et al. Perspectives and Experiences of Doctors and Pharmacists on the Clinical Use of Direct Oral Anticoagulants in Saudi Arabia. Pharmacy (Basel). 2026. DOI: 10.3390/pharmacy14010021

3. Cohen SD, Bouvier F, Tissot CM, et al. Structured pharmaceutical interviews enhance knowledge and medication adherence in DOAC therapy: Insights from the EDUC-AOD study. Patient Education and Counseling. 2026. DOI: 10.1016/j.pec.2025.109423

4. Sirkin NJ, Kolla S, Etkin Y, Oropallo A. Direct oral anticoagulants in patients with venous thromboembolism: current challenges in everyday practice. Polish Archives of Internal Medicine. 2026. DOI: 10.20452/pamw.17192

5. Shrestha O, Joshi H, San S, Richards J. Improving Safe Initiation of Direct Oral Anticoagulant Therapy: A Two-Cycle Quality Improvement Project. Cureus. 2025. DOI: 10.7759/cureus.91646

6. Burnett AE, Mahan CE, Vazquez SR, Oertel LB, et al. Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment. 2016.

7. Barcellona D, Contu P, Marongiu F. Patient education and oral anticoagulant therapy. 2002.

8. Pandya EY, Bajorek B. Factors affecting patients’ perception on, and adherence to, anticoagulant therapy: anticipating the role of direct oral anticoagulants. 2017.

This article was written by the Petit Veinard Editorial Board and reviewed according to our editorial standards. It is for informational and educational purposes only and does not constitute medical advice, diagnosis, or prescription. Anticoagulant therapy should only be started, monitored, and modified under medical supervision. In case of doubt, adverse effects, or emergency, contact your doctor or call emergency services immediately. Petit Veinard is an independent health media outlet and does not provide medical care.